Title
Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children
Phase
Phase 3Lead Sponsor
University of GhanaStudy Type
InterventionalStatus
Unknown statusIndication/Condition
Uncomplicated MalariaIntervention/Treatment
artesunate coartem amodiaquine pyrimethamine ...Study Participants
NoneArtemisinin combination therapies (ACT) are currently recommended for malaria treatment. Artemether-lumefantrine(A-L) and Artesunate+amodiaquine (A+A) have been the most commonly adopted of the recommended ACT regimens. In Ghana, A+A is the current first-line antimalarial treatment in Ghana, but there has been 1 efficacy report of this regimen in Ghana till date. Moreover, the safety of repeated treatments with ACT has been little studied. This study aims to evaluate the efficacy of A+A vs. A-L, as well as the safety of repeated treatments of these regimens in a longitudinal trial in which recruited children will be followed up for 1 year.
Inclusion Criteria: microscopically confirmed acute uncomplicated falciparum malaria; temperature at screening 37.50C or more or history of fever 24 preceding enrollment; willingness to comply with follow up schedule; written informed consent by accompanying parent or guardian Exclusion Criteria: features of severe malaria or danger signs of malaria known intolerance or allergy to any of the study medications known treatment with any of the study medications in the month preceding enrollment serious underlying disease that may mask outcome assessment